CLINICAL ANALYSIS OF ALPROSTADIL COMBINED WITH OCTREOTIDE IN THE TREATMENT OF HYPERLIPIDEMIA ACUTE PANCREATITIS

[Objective]The incidence of hyperlipidemia acute pancreatitis rises quickly,through the analysis of treatment data of hyperlipidemia acute pancreatitis patients in our hospital in 2009,to evaluate the therapeutic effect of alprostadil combined with octreotide for the treatment of hyperlipidemia acute pancreatitis.[Methods]The hyperlipidemia acute pancreatitis patients were randomly divided into treatment group and control group.The cases in two groups were treated with different methods.Based on conventional medical therapy,combination of alprostadil was used in the treatment group,the control group received conventional treatment.After a period of treatment,compared the curative effects between two groups.[Results]After one period of treatment,the negative conversion rate of hemodiastase in the treatment group was significantly higher than that in the control group(P﹤0.05),the difference was statistically significant;the curative effect in the treatment group was better than in the control group(P﹤0.05),the difference was statistically significant.[Conclusion]Alprostadil combined with octreotide therapy can quickly relieve symptoms and signs,improve the cure rate of hyperlipidemia pancreatitis associated with microcirculation disturbance.